Literature DB >> 28685061

Association between risk of type 2 diabetes mellitus and angiotensin-converting enzyme insertion/deletion gene polymorphisms in a Saudi Arabian population.

Fahad I Al-Saikhan1, Mohamed A Abd-Elaziz2, Rehab H Ashour2.   

Abstract

The link between the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and the prevalence of type 2 diabetes mellitus (T2DM) developing in the Saudi Arabian population remains controversial. The aim of the present study was to evaluate the association between the ACE I/D gene polymorphism and the risk of developing T2DM and hypertension (HTN) in Saudi Arabian individuals. A total of 220 individuals consisting of 48 control subjects, 70 T2DM, 48 HTN, and 54 T2DM with HTN patients were recruited. Genotyping was performed by polymerase chain reaction initially and mistyping of the DD genotypes was conducted with an insertion-specific primer. The genotyping frequency for the II, ID and DD polymorphism of the ACE gene was 6.8, 42.6 and 48.6% in T2DM patients, 4.2, 50 and 45.8% in HTN patients, 5.6, 55.5 and 38.9% in T2DM patients with HTN and 58.3, 37.5 and 4.2% in control subjects, respectively. The frequency for the D allele was 70% in T2DM patients, 70.8% in HTN patients and 66.7% in T2DM patients with HTN as compared with 22.9% in the control subjects. The genotype and allele frequency of the ACE gene polymorphism varied significantly (P<0.05) in the patients when compared with the control subjects. The current study demonstrated that the ID/DD genotype and the D allele of the ACE gene I/D polymorphism were strongly associated with the risk of T2DM and HTN developing in a Saudi Arabian population.

Entities:  

Keywords:  angiotensin converting enzyme; hypertension; insertion/deletion gene polymorphism; type 2 diabetes mellitus

Year:  2017        PMID: 28685061      PMCID: PMC5492692          DOI: 10.3892/br.2017.920

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  26 in total

1.  A genotyping exercise for pharmacogenetics in pharmacy practice.

Authors:  Daren L Knoell; Jeffrey S Johnston; Shengying Bao; Katherine A Kelley
Journal:  Am J Pharm Educ       Date:  2009-05-27       Impact factor: 2.047

2.  Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population.

Authors:  F T Chiang; Z P Lai; T H Chern; C D Tseng; K L Hsu; H M Lo; Y Z Tseng
Journal:  Am J Hypertens       Date:  1997-02       Impact factor: 2.689

3.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction.

Authors:  N J Samani; J R Thompson; L O'Toole; K Channer; K L Woods
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

Review 4.  Angiotensin-converting enzyme gene and diabetes mellitus.

Authors:  B Kennon; J R Petrie; M Small; J M Connell
Journal:  Diabet Med       Date:  1999-06       Impact factor: 4.359

Review 5.  Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature.

Authors:  Mohamed Abdulaziz Al Dawish; Asirvatham Alwin Robert; Rim Braham; Ayman Abdallah Al Hayek; Abdulghani Al Saeed; Rania Ahmed Ahmed; Fahad Sulaiman Al Sabaan
Journal:  Curr Diabetes Rev       Date:  2016

6.  Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population.

Authors:  André J Tremblay; Hugo Morrissette; Jean-Marc Gagné; Jean Bergeron; Claude Gagné; Patrick Couture
Journal:  Clin Biochem       Date:  2004-09       Impact factor: 3.281

7.  Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.

Authors:  M Marre; P Bernadet; Y Gallois; F Savagner; T T Guyene; M Hallab; F Cambien; P Passa; F Alhenc-Gelas
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

8.  Associations between hypertension and genes in the renin-angiotensin system.

Authors:  Xiaofeng Zhu; Yen-Pei C Chang; Denise Yan; Alan Weder; Richard Cooper; Amy Luke; Donghui Kan; Aravinda Chakravarti
Journal:  Hypertension       Date:  2003-04-14       Impact factor: 10.190

9.  Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin.

Authors:  J Barley; A Blackwood; N D Carter; D E Crews; J K Cruickshank; S Jeffery; A O Ogunlesi; G A Sagnella
Journal:  J Hypertens       Date:  1994-08       Impact factor: 4.844

10.  Angiotensin-converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan.

Authors:  C H Tseng; C P Tseng; C K Chong; J J Sheu; J C Cheng
Journal:  Eur J Clin Invest       Date:  2007-06       Impact factor: 4.686

View more
  5 in total

1.  Association of ACE I/D gene polymorphism and related risk factors in impaired fasting glucose and type 2 diabetes: a study among two tribal populations of North-East India.

Authors:  Sunanda Rajkumari; Somorjit Singh Ningombam; Varhlun Chhungi; Masan Kambo Newmei; Naorem Kiranmala Devi; Prakash Ranjan Mondal; Kallur Nava Saraswathy
Journal:  Mol Biol Rep       Date:  2021-11-10       Impact factor: 2.316

2.  Association between Angiotensin-Converting Enzyme- Insertion/Deletion Polymorphism and Diabetes Mellitus-2 in Saudi Population.

Authors:  Mahmoud Habibullah; Farhana Akter; Xingping Qin; Mohtashim Lohani; Mohammed S Aldughaim; Yahia Al-Kaabi
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 3.  Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.

Authors:  Iman Akhlaghipour; Amir Reza Bina; Mohammad Reza Mogharrabi; Ali Fanoodi; Amir Reza Ebrahimian; Soroush Khojasteh Kaffash; Atefeh Babazadeh Baghan; Mohammad Erfan Khorashadizadeh; Negin Taghehchian; Meysam Moghbeli
Journal:  Hum Genomics       Date:  2022-04-02       Impact factor: 4.639

4.  Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.

Authors:  Mohammad A Alshabeeb; Mesnad Alyabsi; Bien Paras
Journal:  Saudi Pharm J       Date:  2022-06-22       Impact factor: 4.562

Review 5.  Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.

Authors:  Richard L Jayaraj; Sheikh Azimullah; Rami Beiram
Journal:  Saudi J Biol Sci       Date:  2019-12-26       Impact factor: 4.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.